Results 201 to 210 of about 214,341 (267)

Long-term complete radiological response to immunotherapy in a patient with metastatic NSCLC and active rheumatoid arthritis. [PDF]

Oxf Med Case Reports
Roy E, Jomeh AAE, Xenophontos E, Charalambous H.   +3 more
europepmc   +1 more source

Normoxic HIFα-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity. [PDF]

Cancer Metab
Sánchez-Castillo A, Lommen JGE, Consten D, Savelkouls K, Barbeau LMO, Rouschop KMA, Vooijs MA, Kampen KR.   +7 more
europepmc   +1 more source

Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study. [PDF]

J Immunother Cancer
de Joode K, Groen HJ, Heuvel MVD, Kloover JS, Van Der Meer F, Van der Leest CH, Van Den Borne B, De Wijn R, Hurkmans DP, Van den Heuvel DMA, Pinedo HM, Kapiteijn E, Debets R, Verdegaal EME, Van der Burg SH, Groten JP, Aerts JGJV, Mathijssen RHJ.   +17 more
europepmc   +1 more source

Gene Expression Profiling of EGFR, FGFR2, PIK3CA, PTEN, SMAD4, STK11, and TP53 in Cell-Free RNA From Exhaled Breath Condensate: Diagnostic, Prognostic, and Therapeutic Implications in Advanced Lung Adenocarcinoma. [PDF]

Cancer Rep (Hoboken)
Latifova S, Genis U, Karakus HS, Korba K, Ozgur S, Aldag C, Goksel T, Pelit L, Gunduz C, Vardarli AT.   +9 more
europepmc   +1 more source

Radiation therapy plus osimertinib <i>vs</i> osimertinib alone in epidermal growth factor receptor mutated non-small cell lung cancer: A systematic review. [PDF]

World J Methodol
Javed M, Fatima M, Hassan MB, Kumar S, Pawan R, Singh V, Kumar K, Amir R, Karim A, Jawed I, Alam F, Kumar D, Rai R, Tilokani H, Rizvi SAFA.   +14 more
europepmc   +1 more source

Antibody-Drug Conjugates in Non-small Cell Lung Cancer. [PDF]

Drugs
Zullo L, Bortolot M, Ogliari FR, Saw SPL, van Geel R, Ter Heine R, Sadowska A, Remon J, Hendriks L.   +8 more
europepmc   +1 more source

Lung, NSCLC

Annals of Oncology, 1998
openaire   +1 more source